Keynote Speakers

Dr. Oyedeji Ayonrinde

 Dr. Oyedeji (Deji) Ayonrinde is an Associate Professor of Psychiatry at Queen’s University, Kingston, Ontario.  He is also the Medical Director of the Early Psychosis Intervention Programme in South East Ontario.  

 Dr. Ayonrinde had his postgraduate psychiatry training at the Bethlem and Maudsley Hospitals, London, UK with specialist accreditations in both General Adult and Addiction Psychiatry.  He worked as a Consultant Psychiatrist with South London and Maudsley NHS Foundation Trust and was an Honorary Clinical Senior Lecturer at the Institute of Psychiatry, Psychology and Neuroscience (IOPPN), Kings College, University of London till 2017.

Dr. Ayonrinde has been involved in undergraduate, postgraduate and national medical education for over 20 years and was previously Vice Chair of a General Medical Council education panel. For several years, he has lectured on MSc programmes at University of London, the Institute of Psychiatry and the Medical University of Vienna, Austria. He has also been engaged in knowledge translation initiatives in Malta, Australia, Nigeria and China.

 Dr. Ayonrinde has an MBA from Imperial College Business School, London where he received the Business School Award for research into Organisational Behaviour. A digital innovation by his MBA team was also showcased during the London Olympic Games. 

 In Canada, Dr. Ayonrinde has been involve ...read more



Dr. Pierre Blier

Dr. Pierre Blier is a Full Professor for the Departments of Psychiatry and Cellular & Molecular Medicine in the Faculty of Medicine at the University of Ottawa in Ottawa, Ontario, Canada, and the Director of the Mood Disorders Research Unit at The Royal’s Institute of Mental Health Research.

Dr. Blier is on the editorial boards of several journals and is the co-editor in chief for the Journal of Psychopharmacolgy and field editor for translational medicine for the official journal of International College of Neuropsychopharmacology (CINP).  In addition to his extensive list of publications and lectures presented worldwide, Dr. Blier has contributed to several treatment guidelines for psychiatric disorders. Dr. Blier has a basic research laboratory investigating how psychotropic medications work in the brain, he carries out investigator-initiated clinical studies, and treats patients with mood and anxiety disorders on a daily basis.

Dr. Blier received several awards for outstanding contributions to psychopharmacology including the Canada Research Chair in Psychopharmacology from the Government of Canada and is now a Fellow of the Royal Society of Canada (Life Sciences). He also serves on several committees, including the presidency elect of the CINP.



Dr. Jillann Farmer

Dr Jillann Farmer is the Director of the Medical Services Division of the United Nations, based at the headquarters in New York.  Prior to this, she was the Medical Director of the Patient Safety Centre in Queensland Health, and the inaugural Director of the Clinician Performance Support Service. 

Jillann worked for the Medical Board of Queensland, building the Health Assessment and Monitoring Program for management of registrants with illnesses that impact on their ability to practice.  She also lead a program of national reforms to the way Medicare Australia  interacted with Practitioners whose practice had been identified as significantly different to Peers.   She has been a Director of Medical Services at a mid-size acute Hospital, and a Senior Medical Officer Emergency Medicine.  She holds fellowships of both the RACGP and the College of Medical Administrators. 

In her current role, which she took up in October 2012,  Jillann has overarching responsibility for the UN’s internal healthcare system, which involves care for UN Personnel dispersed throughout the world, sometimes in difficult and dangerous locations.  This includes over 400 healthcare services, ranging from primary care clinics, military forward medical services, to Level 3 hospitals.  She is also the Chair of the UN interagency network of Medical Directors, the peak body for Occupational health in the UN system.

During 2014, ...read more



Dr. Stephan Heres

Assistant Professor Dr. Stephan Heres is a member of the medical faculty at the Technische Universitaet Muenchen, Germany and acts as a senior lecturer of this university as well as the Ludwig-Maximilians-University Muenchen, Germany.

He is Chairman of a psychiatric hospital in the center of Munich with 150 beds, 3 day-care clinics and an outpatient department.

Stephan Heres has his research focus in psychopharmacology, especially in the long-acting formulations of antipsychotics as well as clinical trial design, shared-decision making and meta-analyses in the field of schizophrenia. Over the last 19 years he has participated in, conducted and designed more than 65 clinical trials. He has developed and chaired the specialized outpatient department for long-acting injection treatment (“OASIS project”) at the Technische Universitaet Muenchen for more than 10 years.         



Dr. Ron Lim

Dr. Ron Lim BSc MD, CCFP, DFASAM, CSAM (Certificant), ABAM (Diplomate), ISAM (Certification)

Dr. Lim completed his medical school at the University of British Columbia. He did a rotating Internship at the Royal Alex Hospital in Edmonton and completed 2 years of Internal Medicine training at the University of Calgary (U of C).

Dr. Lim is currently an Assistant Professor in the Departments of Psychiatry and Family Medicine at the Cumming School of Medicine, U of C. He is also the Region IX Director for ASAM until 2017, the past President Section of Addiction Medicine for the Alberta Medical Association and the Director of the R3 Enhanced Skills Addiction Medicine Program for the Department of Family Medicine at the U of C.

Dr. Lim is a peer reviewer for the Canadian Journal of Addiction and Journal of Addiction Medicine. He is also a Prairie Node Regional Principal Investigator for the Canadian Research Initiative in Substance Misuse's OPTIMA trial comparing methadone and buprenorphine/naloxone in patients with prescription opioid dependence.



Dr. Mary L. Phillips

Dr. Mary Phillips is the Pittsburgh Foundation-Emmerling Endowed Chair in psychotic Disorders, and Professor in Psychiatry and Clinical and Translational Science in the University of Pittsburgh. She heads the Clinical and Translational Affective Neuroscience Program in the Department of Psychiatry at the University of Pittsburgh. Dr. Phillips’ research focuses on using multimodal neuroimaging techniques to elucidate functional and structural abnormalities in emotion processing, reward processing and emotional regulation circuitries that are associated with specific psychiatric disorders, and symptom dimensions in individuals with mood and anxiety disorders. Her research also focuses on identifying the neurodevelopmental trajectories in these circuitries that are associated with the development of such disorders in youth and infants, and the extent to which these neuroimaging techniques can identity biomarkers reflecting underlying pathophysiologic processes that denote future risk for these disorders in as yet unaffected youth. Her more recent work examines how neuromodulation techniques can be targeted on identified neural biomarkers of mood disorders, as a step toward developing new interventions for individuals with these disorders. She works in collaboration with basic neuroscientists in translational studies of neural circuitry abnormalities in these disorders. 

Dr. Phillips trained in Medicine at Cambridge University, UK, and in Psychiatry at the Ma ...read more



Dr. Michael Travis

The University of Pittsburgh School of Medicine has appointed Michael J. Travis, MD, to a five-year term to the Academy of Master Educators (AME). The appointment recognizes Dr. Travis' sustained record of excellence and achievements in medical education.

Dr. Travis is an Associate Professor of Psychiatry and serves as the Director of Residency Training at Western Psychiatric Institute and Clinic. He trained in medicine at Guy's Hospital and in psychiatry at St. Bartholomew's and Hackney Hospitals, and The Royal Bethlem and Maudsley Hospitals in London in the UK. Prior to joining the Department faculty, he held academic and clinical positions at Bethlem and Maudsley Hospitals, and at the Institute of Psychiatry in London. Dr. Travis has been involved in educational and research activities throughout his career and has a diverse set of research interests. In addition to educational research, he has collaborated on studies exploring drug action and neural systems using functional and neurochemical imaging. He is also the co-author of an article appearing in Academic Psychiatry that highlighted our Department's Academic Administrator Clinician Educator Track. Dr. Travis has presented posters and workshops at the annual American Association of Directors of Psychiatric Residency Training (AADPRT) meeting, and also serves as a member of the AADPRT's Clinical Neuroscience Training Taskforce and is the Chair of the Ginsberg Committee.